These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 31597098)

  • 1. Disrupting Myelin-Specific Th17 Cell Gut Homing Confers Protection in an Adoptive Transfer Experimental Autoimmune Encephalomyelitis.
    Duc D; Vigne S; Bernier-Latmani J; Yersin Y; Ruiz F; Gaïa N; Leo S; Lazarevic V; Schrenzel J; Petrova TV; Pot C
    Cell Rep; 2019 Oct; 29(2):378-390.e4. PubMed ID: 31597098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAdCAM-1-Mediated Intestinal Lymphocyte Homing Is Critical for the Development of Active Experimental Autoimmune Encephalomyelitis.
    Kuhbandner K; Hammer A; Haase S; Terbrack E; Hoffmann A; Schippers A; Wagner N; Hussain RZ; Miller-Little WA; Koh AY; Stoolman JS; Segal BM; Linker RA; Stüve O
    Front Immunol; 2019; 10():903. PubMed ID: 31114574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta7 integrins contribute to demyelinating disease of the central nervous system.
    Kanwar JR; Harrison JE; Wang D; Leung E; Mueller W; Wagner N; Krissansen GW
    J Neuroimmunol; 2000 Mar; 103(2):146-52. PubMed ID: 10696909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha4 beta7 integrin controls Th17 cell trafficking in the spinal cord leptomeninges during experimental autoimmune encephalomyelitis.
    Rossi B; Dusi S; Angelini G; Bani A; Lopez N; Della Bianca V; Pietronigro EC; Zenaro E; Zocco C; Constantin G
    Front Immunol; 2023; 14():1071553. PubMed ID: 37143680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System.
    Dusi S; Angiari S; Pietronigro EC; Lopez N; Angelini G; Zenaro E; Della Bianca V; Tosadori G; Paris F; Amoruso A; Carlucci T; Constantin G; Rossi B
    Front Immunol; 2019; 10():2436. PubMed ID: 31681316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
    Kong W; Li H; Tuma RF; Ganea D
    Cell Immunol; 2014 Jan; 287(1):1-17. PubMed ID: 24342422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective accumulation of pro-inflammatory T cells in the intestine contributes to the resistance to autoimmune demyelinating disease.
    Berer K; Boziki M; Krishnamoorthy G
    PLoS One; 2014; 9(2):e87876. PubMed ID: 24504092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pertussis Toxin Inhibits Encephalitogenic T-Cell Infiltration and Promotes a B-Cell-Driven Disease during Th17-EAE.
    Maria Z; Turner E; Agasing A; Kumar G; Axtell RC
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TET inducible expression of the α4β7-integrin ligand MAdCAM-1 on the blood-brain barrier does not influence the immunopathogenesis of experimental autoimmune encephalomyelitis.
    Döring A; Pfeiffer F; Meier M; Dehouck B; Tauber S; Deutsch U; Engelhardt B
    Eur J Immunol; 2011 Mar; 41(3):813-21. PubMed ID: 21341265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STEAP4 expression in CNS resident cells promotes Th17 cell-induced autoimmune encephalomyelitis.
    Zhao J; Liao Y; Miller-Little W; Xiao J; Liu C; Li X; Li X; Kang Z
    J Neuroinflammation; 2021 Apr; 18(1):98. PubMed ID: 33879167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR7 on CD4
    Belikan P; Bühler U; Wolf C; Pramanik GK; Gollan R; Zipp F; Siffrin V
    J Immunol; 2018 Apr; 200(8):2554-2562. PubMed ID: 29549177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
    Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
    Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation.
    Quinn JL; Kumar G; Agasing A; Ko RM; Axtell RC
    Front Immunol; 2018; 9():382. PubMed ID: 29535739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
    Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
    J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing c-Rel in macrophages dampens Th1 and Th17 immune responses and alleviates experimental autoimmune encephalomyelitis in mice.
    Zhang H; Bi J; Yi H; Fan T; Ruan Q; Cai L; Chen YH; Wan X
    Immunol Cell Biol; 2017 Aug; 95(7):593-600. PubMed ID: 28202908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
    Chung CY; Liao F
    J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells.
    Nouri M; Bredberg A; Weström B; Lavasani S
    PLoS One; 2014; 9(9):e106335. PubMed ID: 25184418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dulaglutide Modulates the Development of Tissue-Infiltrating Th1/Th17 Cells and the Pathogenicity of Encephalitogenic Th1 Cells in the Central Nervous System.
    Chiou HC; Lin MW; Hsiao PJ; Chen CL; Chiao S; Lin TY; Chen YC; Wu DC; Lin MH
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aurintricarboxylic acid ameliorates experimental autoimmune encephalomyelitis by blocking chemokine-mediated pathogenic cell migration and infiltration.
    Zhang F; Wei W; Chai H; Xie X
    J Immunol; 2013 Feb; 190(3):1017-25. PubMed ID: 23267022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.